Morgan Stanley

13F Holdings History for Pulmonx Corp - COM (LUNG)

Symbol: LUNG on Nasdaq
Investment type: Equity / COM
Latest Disclosed Ownership: 3.39M shares
Security Ownership: 8.5%

Shares, Excluding Options vs Price

Value, Excluding Options

Morgan Stanley ownership in Pulmonx Corp COM (LUNG)

2025-05-07 - Morgan Stanley has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3.39M shares of Pulmonx Corp COM (LUNG). This represents 8.5% percent ownership of the company. In their previous filing dated 2025-02-04, MORGAN STANLEY had reported owning 2.97M shares, indicating an increase of 14.4% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Morgan Stanley	8.5%	+12.5%	$22.8M	3.39M	+425,542	+14.4%	$6.73	13G/A	3/31/2025	7 May 2025 11:47:10
Morgan Stanley	7.5%		$20M	2.97M			$6.73	13G/A	12/31/2024	4 Feb 2025 12:45:36

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0%	+0%	$5.87M	3.62M	+63,628	+1.79%	$1.62	Q3 2025
6/30/2025	0%	+0%	$9.21M	3.56M	+62,919	+1.8%	$2.59	Q2 2025
3/31/2025	0%	+0%	$23.5M	3.49M	+421,291		$6.73	Q1 2025
12/31/2024	0%	0%	$20.9M	3.07M	-716,106		$6.79	Q4 2024
9/30/2024			$14.00	1			$14.00^*	Q3 2024
9/30/2024	0%	+0%	$31.4M	3.79M	+317,867		$8.29	Q3 2024
6/30/2024	0%	+0%	$22M	3.47M	+819,632		$6.34	Q2 2024
3/31/2024	0%		$24.6M	2.65M			$9.27	Q1 2024
3/31/2024	0%		$24.6M	2.65M			$9.27^*	Q1 2024
12/31/2023	0%		$29.1M	2.28M			$12.75	Q4 2023
9/30/2023	0%	+0%	$22.9M	2.22M	+246,302	+12.5%	$10.33^*	Q3 2023
6/30/2023	0%	0%	$25.9M	1.97M	-640,847	-24.5%	$13.11	Q2 2023
3/31/2023	0%	+0%	$29.2M	2.61M	+463,866	+21.6%	$11.18	Q1 2023
12/31/2022	0%	+0%	$18.1M	2.15M	+296,693	+16%	$8.43	Q4 2022
9/30/2022	0%	0%	$30.9M	1.85M	-273,953	-12.9%	$16.66^*	Q3 2022
6/30/2022	0%	+0%	$31.3M	2.13M	+1,897,698	+825%	$14.72	Q2 2022
3/31/2022	0%	+0%	$5.71M	230K	+163,026	+243%	$24.81	Q1 2022
12/31/2021	0%	+0%	$2.15M	67K	+48,174	+255%	$32.08	Q4 2021
9/30/2021	0%	0%	$680K	18.9K	-46,163	-71%	$36.04	Q3 2021
6/30/2021	0%	+0%	$2.87M	65K	+20,527	+46.1%	$44.13	Q2 2021
3/31/2021	0%	+0%	$2.04M	44.5K	+30,316	+214%	$45.75	Q1 2021
12/31/2020	0%	+0%	$979K	14.2K	+14,187	NEW	$69.01	Q4 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.